|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | Uruguay

Latin America’s First Lab for Cannabis-Based Medications Opens in Uruguay

MONTEVIDEO – Uruguay inaugurated the first laboratory of cannabis-derived pharmaceuticals in Latin America on Wednesday.

Uruguayan President Tabare Vazquez cut the ribbon symbolically opening the lab in the southern province of Canelones, later taking a tour of the facility’s interior.

The project was launched by ICC Labs Inc., a newly acquired subsidiary of Canada’s Aurora Cannabis Inc.

At a press conference, ICC Labs CEO Alejandro Antalich declared that the laboratory has the “production capacity to supply almost the entire South American continent.”

He also suggested that the lab will also have the capacity to supply Central America and Mexico.

“For a long time, Uruguay was known as the Switzerland of the Americas. I believe that today, with the help of Aurora, and considering that we are creating a new industry in Uruguay, we have the possibility of being known as the Switzerland of the Americas again,” Antalich said.

The lab represents an investment of roughly $12 million, he said.

“The most important thing for the company was always to be able to vertically integrate the entire production matrix in Uruguay, which allows us to have very low production costs and makes us a very competitive actor worldwide,” he said.

Although the final price of the medications was not revealed, Antalich said that they will be “accessible” and that a program will be created whereby Uruguayan families with low economic resources can access the products made in this laboratory for free.

Uruguay was the first country to legalize marijuana in 2013 and in July 2017 the legal sale of marijuana for recreational purposes was begun in pharmacies.

 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2018 © All rights reserved